Triopsy Biopsy System

About Triopsy

Triopsy is a private, early-stage medical device and digital health company focused on transforming the prostate biopsy procedure. Its core innovation is a fully integrated system comprising a specialized needle, an actuator for controlled sampling, a specimen transport container, and cloud-based laboratory software, all working together to standardize the biopsy workflow from procedure to pathology. The company targets the significant clinical problem of biopsy sampling error and tissue fragmentation, which can lead to misdiagnosis and delayed treatment in prostate cancer. By improving tissue yield and integrity, Triopsy seeks to enhance diagnostic accuracy, streamline clinician collaboration, and ultimately improve patient care.

Therapeutic Areas

Other Prostate Cancer Diagnosis Drugs